108 related articles for article (PubMed ID: 14523284)
1. Structured interruptions of therapy: looking for the best protocol.
Aiuti F; Giovannetti A
AIDS; 2003 Oct; 17(15):2257-8. PubMed ID: 14523284
[No Abstract] [Full Text] [Related]
2. Treatment interruption in HIV therapy: a SMART strategy?
Jülg B; Goebel FD
Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667
[TBL] [Abstract][Full Text] [Related]
3. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
[No Abstract] [Full Text] [Related]
4. Darunavir: after multiple antiretroviral treatment failure: another option.
Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
[TBL] [Abstract][Full Text] [Related]
5. A model predictive control strategy toward optimal structured treatment interruptions in anti-HIV therapy.
Pannocchia G; Laurino M; Landi A
IEEE Trans Biomed Eng; 2010 May; 57(5):1040-50. PubMed ID: 20172797
[TBL] [Abstract][Full Text] [Related]
6. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
[No Abstract] [Full Text] [Related]
7. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
Krogstad PA
J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
[No Abstract] [Full Text] [Related]
8. [Antiretroviral therapy suppression: already a new strategy?].
Viciana Fernández P; Mata Alcázar-Caballero R; López Cortés LF
Farm Hosp; 2004; 28(6 Suppl 1):85-91. PubMed ID: 15649120
[No Abstract] [Full Text] [Related]
9. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.
Cuzin L; Delpierre C; Gerard S; Massip P; Marchou B
Clin Infect Dis; 2007 Sep; 45(5):654-7. PubMed ID: 17683004
[TBL] [Abstract][Full Text] [Related]
10. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
11. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K
Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420
[TBL] [Abstract][Full Text] [Related]
12. Intermittent therapy for the treatment of chronic HIV infection.
Ananworanich J; Hirschel B
AIDS; 2007 Jan; 21(2):123-34. PubMed ID: 17197802
[No Abstract] [Full Text] [Related]
13. Trying to make sense of treatment interruptions.
Lewis D; Sutton RE
Res Initiat Treat Action; 2003; 9(2):14-5. PubMed ID: 14989200
[No Abstract] [Full Text] [Related]
14. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
15. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
[TBL] [Abstract][Full Text] [Related]
16. [HIV-infection].
Wasmuth JC; Rockstroh JK
Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
[No Abstract] [Full Text] [Related]
17. Treatment strategies for highly treatment-experienced HIV-infected patients.
Luber AD
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):815-23. PubMed ID: 16207173
[TBL] [Abstract][Full Text] [Related]
18. Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
Nüesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B
AIDS; 2008 Jan; 22(1):152-4. PubMed ID: 18090405
[TBL] [Abstract][Full Text] [Related]
19. Ask the experts.
Kaiser JD
Explore (NY); 2006; 2(5):471-2. PubMed ID: 16979115
[No Abstract] [Full Text] [Related]
20. The long-term consequences of antiretroviral therapy.
Smith D
J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
